These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 20356963)

  • 21. [Neuroleptic malignant syndrome in users of risperidone].
    van Bemmel T; Westendorp RG
    Ned Tijdschr Geneeskd; 2005 Mar; 149(11):608; author reply 608. PubMed ID: 15799646
    [No Abstract]   [Full Text] [Related]  

  • 22. A case of clozapine intoxication presenting with atypical NMS symptoms.
    Kamış GZ; Ayhan Y; Basar K; Özer S; Anıl Yağcıoğlu AE
    Int J Neuropsychopharmacol; 2014 May; 17(5):819-21. PubMed ID: 24438505
    [No Abstract]   [Full Text] [Related]  

  • 23. [Neuroleptic malignant syndrome].
    Bryois C; Bondolfi G
    Rev Med Suisse Romande; 1996 Sep; 116(9):713-7. PubMed ID: 8966472
    [No Abstract]   [Full Text] [Related]  

  • 24. Neuroleptic malignant syndrome related to use of clozapine.
    Trayer JS; Fidler DC
    J Am Osteopath Assoc; 1998 Mar; 98(3):168-9. PubMed ID: 9558834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroleptic malignant syndrome associated with risperidone in a male with early-onset schizophrenia.
    Mané A; Baeza I; Morer A; Lázaro ML; Bernardo M
    J Child Adolesc Psychopharmacol; 2005 Dec; 15(6):844-5. PubMed ID: 16379503
    [No Abstract]   [Full Text] [Related]  

  • 26. Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment.
    Ozen ME; Yumru M; Savas HA; Cansel N; Herken H
    World J Biol Psychiatry; 2007; 8(1):42-4. PubMed ID: 17366349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinico-therapeutic observations in the neuroleptic malignant syndrome].
    Grecu G; Grecu-Gaboş M; Nireşteanu A; Grecu-Gaboş I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1989; 34(4):267-76. PubMed ID: 2577227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Malignant neuroleptic syndrome in patients with dementia].
    Malling BJ
    Ugeskr Laeger; 1999 Apr; 161(17):2541-2. PubMed ID: 10327877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risperidone-induced hyperamylasemia, hyperlipasemia, and neuroleptic malignant syndrome: a case report.
    Ghio L; Fornaro G; Rossi P
    J Clin Psychopharmacol; 2009 Aug; 29(4):391-2. PubMed ID: 19593182
    [No Abstract]   [Full Text] [Related]  

  • 30. ECT as a treatment alternative for patients with symptoms of neuroleptic malignant syndrome.
    Addonizio G; Susman VL
    J Clin Psychiatry; 1987 Mar; 48(3):102-5. PubMed ID: 2880837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical differentiation between lethal catatonia and neuroleptic malignant syndrome: a case report].
    Terlikowska M; Marzański M
    Psychiatr Pol; 1995; 29(3):343-8. PubMed ID: 7652087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroleptic malignant syndrome: an experience of four cases.
    Desai ND; Mundra VK; Gore YS; Diwan PJ; Jaydeokar SS; Jain V; Sutharsan R; Agarwal A; Moulick ND; Manocha SM
    J Assoc Physicians India; 1998 Jul; 46(7):653-4. PubMed ID: 12152854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The neuroleptic malignant syndrome].
    Dammers S; Zeit T; Leonhardt M; Schär V; Agelink MW
    Dtsch Med Wochenschr; 1995 Dec; 120(50):1739-42. PubMed ID: 8542810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Neuroleptic malignant syndrome (dopamine-dependent malignant hyperthermia). 4 different cases].
    Truong DD; Sczesni B; Fahn S; Gross J; Donovan K; van Bakel A; Wiley MK
    Nervenarzt; 1988 Feb; 59(2):103-9. PubMed ID: 2896306
    [No Abstract]   [Full Text] [Related]  

  • 35. [The risperidone-associated neuroleptic malignant syndrome in a pediatric patient].
    Villanueva Lamas J; García García J; Alda Diez JA; Tous Andreu N
    An Esp Pediatr; 1998 Dec; 49(6):652-3. PubMed ID: 9972639
    [No Abstract]   [Full Text] [Related]  

  • 36. Neuroleptic malignant syndrome: case report and review.
    Dykstra TJ; Menolasino MJ
    J Am Osteopath Assoc; 1997 Jun; 97(6):355-7. PubMed ID: 9232946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroleptic malignant syndrome in an afebrile patient on second generation antipsychotics.
    Chee A; Tay KH; Yap PP; Kwok V; Rawtaer I
    Asian J Psychiatr; 2020 Apr; 50():101938. PubMed ID: 32109803
    [No Abstract]   [Full Text] [Related]  

  • 38. [The application of electroconvulsive therapy in neuroleptic malignant syndrome treatment in patient with catatonic schizophrenia].
    Kucia K; Warchala A
    Wiad Lek; 2005; 58(9-10):572-4. PubMed ID: 16529073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroleptic malignant syndrome and its controversies.
    Margetić B; Aukst-Margetić B
    Pharmacoepidemiol Drug Saf; 2010 May; 19(5):429-35. PubMed ID: 20306454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Catatonia and neuroleptic malignant syndrome in a mentally retarded patient].
    Heikkilä J; Raitasuo S; Lauerma H; Mölsä P
    Duodecim; 1992; 108(12):1120-4. PubMed ID: 1366062
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.